Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy

Epilepsy Clinical Trial

— NENUFAR  

Official title:

Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06105645
• Other study ID #: RC31/22/0260
• Secondary ID: 2022-A02552-41
• Status: Recruiting
• Phase: N/A
• Start date: January 19, 2024
• Est. completion date: April 2030

Study information

• Verified date: May 2024
• Source: University Hospital, Toulouse
• Contact: Luc VALTON, MD
• Phone: 0561775608
• Email: valton.l[@]chu-toulouse.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main aim of this study is to evaluate the contribution of fast-ripples (FR) information on the neurosurgery management of patients with drug-refractory epilepsy investigated by Stereo-ElectroEncephaloGraphy (SEEG), as measured by freedom from disabling seizures one-year post-surgery.

220 patients (for whom 4-6 usual clinical macro-electrodes will be replaced by hybrid micro-macro electrodes and for whom fast-ripples will be assessed) distributed over 5 centres and 220 control patients(who will undergo an SEEG with the usual electrodes and for whom fast-ripples will not be assessed) distributed over 6 centres. This is a controlled, non-randomized, parallel plan, prospective, multicentre exploratory study.

Description:

This is a controlled, non-randomized, parallel plan, prospective, multicentre exploratory study. The design of the study relies on two groups of patients benefiting from a SEEG, equivalent in size: one with standard and hybrid electrodes for which fast-ripple information will be available for the neurosurgery decision, the other, who will serve as a control group, with standard electrodes only and for which no information regarding fast-ripples will be provided. For all patients undergoing SEEG, the decisions about eligibility to epilepsy surgery and, if eligible, about the best surgical plan, are taken during a multidisciplinary epilepsy meeting (MEM) within the 4 +/- 2 months following the SEEG. In the group of patients with standard and hybrid electrodes, the procedure as extensively tested previously, is to plan the implantation of the standard electrodes as usually done, and once done, to replace from 4 to 6 standard electrodes with hybrid electrodes. In this group, intracerebral ElectroEncephaloGraphy (EEG) data will be acquired for detection of fast-ripples, during one hour of a rest period for 2 days during the first week of SEEG, as well as during one cycle of night sleep when possible. Fast-ripples(number, localization and characteristics) for all these patients will be analysed by an expert group of neuroscientists based in Toulouse blind to the analysis of the Epileptogenic Zone (EZ), irritative and propagation zones and on all micro- and macro contacts, to the participating centre and to the period of recording. The results of the fast-ripple assessment will be provided to the clinicians on time for the MEM. They will incorporate this information along other usual clinical information gathered during the SEEG to reach a conclusion regarding the possibility of a neurosurgery. No analysis of the fast-ripples will be performed in the other group of patients with standard electrodes only. In this group, the conclusion regarding the possibility of a neurosurgery will thus be done during the MEM with the standard clinical information gathered during the SEEG only. Following epilepsy surgery, the typical follow-up performed in routine in all participating centres includes a clinical evaluation one year after surgery, during which Engel class is assessed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 440
• Est. completion date: April 2030
• Est. primary completion date: April 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patient suffering from drug-resistant focal epilepsy (DRFE), as defined by the International League Against Epilepsy, undergoing SEEG, the indication of which was selected during a multidisciplinary epilepsy meeting

• Patient who has given written informed consent to allow the study data collection procedures

• Patient covered by the French healthcare system.

Exclusion Criteria:

• Patients under juridical protection (authorship, curators or safeguarding of justice).

• Patient deprived of liberty by a judicial or administrative decision

• Patient with a cardiac defibrillator

• Thermocoagulation planned on one of the potential hybrid electrodes .

• Patient in exclusion period of another study.

• No other non-inclusion criteria since the study will only be proposed to patients who already meet the criteria for a SEEG

Related Conditions & MeSH terms

• Drug Resistant Epilepsy
• Epilepsy

Intervention

Device:
• DIXI Medical Microdeep® Micro- Macro Depth electrodes
It is a deep intracerebral electrode used in the pre-surgical diagnosis of certain drug-resistant epilepsies. It consists of micro- and macro-contacts and is designed for Stereo-ElectroEncephalography (SEEG) recording via the macro-contacts or micro-contacts and brief stimulation via the macro-contacts.
• Standard electrodes
Standard electrodes used usually during the SEEG

Locations

Country	Name	City	State
France	CHU Amiens Picardie	Amiens
France	CHU de Lille	Lille
France	Hospices Civils de Lyon	Lyon
France	CHRU de Nancy	Nancy
France	CHU de Rennes	Rennes
France	Hôpitaux universitaires de Strasbourg	Strasbourg
France	University Hospital of Toulouse	Toulouse

Sponsors (3)

Lead Sponsor	Collaborator
University Hospital, Toulouse	Centre de recherche Cerveau et Cognition (CERCO), Dixi Medical

Country where clinical trial is conducted

France, 

References & Publications (1)

Despouy E, Curot J, Reddy L, Nowak LG, Deudon M, Sol JC, Lotterie JA, Denuelle M, Maziz A, Bergaud C, Thorpe SJ, Valton L, Barbeau EJ. Recording local field potential and neuronal activity with tetrodes in epileptic patients. J Neurosci Methods. 2020 Jul 15;341:108759. doi: 10.1016/j.jneumeth.2020.108759. Epub 2020 May 7. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Contribution of fast-ripples information on freedom seizures	Proportion of patients with Engel class I after one-year post-surgery in the group of patients with information of fast-ripples compared to patients without.	12 months after epilepsy surgery
Secondary	Contribution of fast-ripples information on improvement of epilepsy	Proportion of patients with Engel classes I to III one-year post-surgery of patients with information of fast-ripples compared to patients without.	12 months after epilepsy surgery
Secondary	Contribution of fast-ripples information on patients addressed to neurosurgery	Proportion of patients operated for their epilepsy in the group of patients with information of fast-ripples compared to patients without.	12 months after epilepsy surgery
Secondary	Adverse effects related to Stereo-electroencephalography	Quantitative and qualitative description of adverse effects related to the Stereo-electroencephalography (SEEG) in the group of patients with information of fast-ripples compared to patients without.	Day 0 (SEEG visit)
Secondary	Adverse effects of epilepsy surgery	Quantitative and qualitative description of adverse effects related to epilepsy surgery in the group of patients with information of fast-ripples compared to patients without.	6 months after surgical decision
Secondary	Adverse effects of hybrid electrodes	Quantitative and qualitative description of adverse effects related to the hybrid electrodes.	Day 0 (SEEG visit)
Secondary	Post-operative neurological deficit	Number of patients suffering from disabling post-operative neurological deficit, anxiety or depression in the group of patients with information of fast-ripples versus patients without	12 months after epilepsy surgery
Secondary	Evolution of quality of life using the score of Quality of life Epilepsy Inventory Epilepsy Inventory	Delta of quality of life using the score of Quality of life Epilepsy Inventory (QOLIE-31) between baseline and 12 months related to epilepsy surgery in the group of patients with information of fast-ripples compared to patients without.; QOLIE-31 is a 31-item questionnaire with different proposal scores. The maximal total score is 100 : the higher the score, the better the quality of life	12 months after epilepsy surgery
Secondary	Level of satisfaction	Mean of level of satisfaction with the outcome of epilepsy surgery assessed using the Evaluation of changes in daily life after epilepsy surgery (EVOCQUE) self-questionnaire, 12 months after surgery, related to epilepsy surgery in the group of patients with information of fast-ripples compared to patients without.; EVOCQUE is a self-questionnaire with ten different questions and proposal scores.	12 months after epilepsy surgery
Secondary	Recording of fast-ripples	Number of fast-ripples recorded on the hybrid electrodes, on the one hand on the micro- contacts and on the other hand on the adjacent macro-contacts of the same hybrid electrode.	Day 0 (SEEG visit)
Secondary	Distribution of the fast-ripples	Number of fast-ripples in the Epileptogenic Zone, Irritative Zone and healthy zone	Day 0 (SEEG visit)
Secondary	Number of fast-ripples recorded according to the period	Number of fast-ripples recorded during one period of sleep, an equivalent period of nap and an equivalent period of sitcom watching.	Day 0 (SEEG visit)